Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Drug Development

      Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

      FDA Approvals
      Samsung Biologics announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy,...

      Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

      Clinical Trials
      Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company is pleased to announce that it has decided to review its protocol for its phase...

      Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

      FDA Approvals
      Samsung Biologics announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy,...

      Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

      Clinical Trials
      Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines administered by tablet, announced preliminary data from its Phase 1 study of VXA-CoV2-1 showing that...

      GSK and CureVac to develop next generation mRNA COVID-19 vaccines

      Drug Development
      GlaxoSmithKline plc and CureVac N.V. announced a new €150m collaboration, building on their existing relationship, to jointly develop next generation mRNA vaccines for COVID-19...

      Oxford leads first trial investigating dosing with alternating vaccines

      Drug Development
      The University of Oxford is to lead the first trial to explore alternating different COVID-19 vaccines, to explore the potential for flexibility in delivery...

      Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines

      Drug Development
      Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it is expanding its pipeline of innovative vaccines with three...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.